Skip to main content

Structural Racism Tied to Elevated Cancer Risk From Traffic Pollutants

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 26, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Aug. 26, 2024 -- Multidimensional structural racism is associated with elevated cancer risk from traffic-related air pollutants, according to a study published online Aug. 26 in Cancer.

Emily B. White, M.P.H., and Christine C. Ekenga, Ph.D., M.P.H., from Emory University in Atlanta, examined the relationship between structural racism and estimated cancer risk from air pollutants in Georgia using a multidimensional measure of structural racism, including county‐level data on residential segregation, education, employment, incarceration, economic status, political participation, and home ownership.

The researchers observed a significant association between multidimensional structural racism and exposure to carcinogenic traffic-related air pollutants in multilevel analyses. Compared with neighborhoods with lower levels of structural racism, those in the highest quartile of structural racism exhibited an elevated cancer risk from traffic-related air pollutants (relative risk, 7.84).

"By highlighting the link between structural inequalities and environmental health risks, our study underscores the importance of addressing social and systemic issues to improve public health outcomes," Ekenga said in a statement. "This study can inform policymakers about the need for targeted interventions to reduce exposure to traffic-related air pollutants."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted August 2024

Read this next

American Society of Clinical Oncology, May 31-June 3

The annual meeting of the American Society of Clinical Oncology was held from May 31 to June 3 in Chicago and hosted more than 35,000 participants, including clinicians...

Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer

MONDAY, June 9, 2025 -- For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated with improved survival and...

Obesity Linked to Subsequent Neoplasms in Childhood Cancer Survivors

FRIDAY, June 6, 2025 -- Body mass index (BMI) and physical activity are associated with the risk for subsequent neoplasms among childhood cancer survivors, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.